D6567

DRF 2519

≥98% (HPLC), solid

• 別名: 5-[[4-[2-(4-Oxo-2H-1,3-benzoxazin3(4H)-yl)ethoxy]phenyl]methyl2,4-thiazolidinedione
• 実験式（ヒル表記法）: C₂₀H₁₈N₂O₅S
• 分子量: 398.43
• MDL番号: MFCD06798336
• UNSPSCコード: 12352200
• PubChem Substance ID: 24894036

特性

• アッセイ: ≥98% (HPLC)
• 形状: solid
• 保管条件: under inert gas
• 色: white
• 溶解性: DMSO: ≥10 mg/mL
• 保管温度: 2-8°C
• SMILES記法: O=C1NC(=O)C(Cc2ccc(OCCN3COc4ccccc4C3=O)cc2)S1

詳細

生物化学的／生理学的作用

DRF-2519 is a dual PPARα/γ activator. DRF-2519 has better reduction of plasma insulin, triglyceride, and free fatty acid levels than those treated with rosiglitazone.

安全性情報

• 保管分類コード: 13 - Non Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable
• 個人用保護具 (PPE): Eyeshields, Gloves, type N95 (US)